29.05.2013 19:20 Uhr, Quelle: Wallstreet online
DGAP-Adhoc: GSK and Genmab Announce Positive Top-line Results from Pivotal Study of ARZERRA(r) (ofatumumab) Combined with Chlorambucil in Previously Untreated Chronic Lymphocytic Leukemia
Genmab A/S 29.05.2013 19:05 Dissemination of a Adhoc News, transmitted by DGAP - a company of EquityStory AG. The issuer is solely responsible for the content of this …
Weiterlesen bei Wallstreet online
JustMac.info